Cancer drug price cap: Thiotepa gets 91% cut, Keytruda remains at Rs 2.16 lakh [see revised prices]

Posted
The highest reductions were seen in the chemotherapy medicines Thiotepa for which the price goes down from Rs 80,071 to Rs 7,150 for a 100mg vial. This was followed by the breast cancer immunotherapy drug Pertuzumab for which the prices reduced from Rs 94,951 to Rs 30,593 for a 30mg vial

Continue reading at IB Times »